Self-managed medication abortion outcomes: results from a prospective pilot study
- PMID: 33109230
- PMCID: PMC7588945
- DOI: 10.1186/s12978-020-01016-4
Self-managed medication abortion outcomes: results from a prospective pilot study
Abstract
Background: To evaluate the feasibility of conducting a prospective study to measure self-managed medication abortion outcomes, and to collect preliminary data on safety and effectiveness of self-managed medication abortion, we recruited callers to accompaniment groups (volunteer networks that provide counselling through the out-of-clinic medication abortion process by trained counselors over the phone or in-person).
Methods: In 2019, we enrolled callers to three abortion accompaniment groups in three countries into a prospective study on the safety and effectiveness of self-managed medication abortion with accompaniment support. Participants completed up to five interview-administered questionnaires from baseline through 6-weeks after taking the pills. Primary outcomes included: (1) the number of participants enrolled in a 30-day period, (2) the proportion that had a complete abortion; and (3) the proportion who experienced any warning signs of potential or actual complications.
Results: Over the 30-day recruitment period, we enrolled 227 participants (95% of those invited), and retained 204 participants (90%) for at least one study follow-up visit. At the 1-week follow-up, two participants (1%) reported a miscarriage prior to taking the pills, and 202 participants (89% of those enrolled and 99% of those who participated in the 1-week survey) had obtained and taken the medications. Three weeks after taking the medications, 192 (95%) participants reported feeling that their abortion was complete. Three (1.5%) received a surgical intervention, two (1%) received antibiotics, and five (3%) received other medications. Participants did not report any major adverse events.
Conclusion: These results establish the feasibility of conducting prospective studies of self-managed medication abortion in legally restrictive settings. Further, the high effectiveness of self-managed medication abortion with accompaniment support reported here is consistent with high levels of effectiveness reported in prior studies. Trial registration ISRCTN95769543.
Keywords: Abortion; Accompaniment; Africa; Mifepristone; Misoprostol; Self-managed abortion; South America; Southeast Asia.
Conflict of interest statement
We have no competing interests to declare.
Figures
Similar articles
-
Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls.Lancet Glob Health. 2022 Jan;10(1):e105-e113. doi: 10.1016/S2214-109X(21)00461-7. Epub 2021 Nov 18. Lancet Glob Health. 2022. PMID: 34801131 Free PMC article.
-
Effectiveness of Self-Managed Medication Abortion Between 9 and 16 Weeks of Gestation.Obstet Gynecol. 2023 Aug 1;142(2):330-338. doi: 10.1097/AOG.0000000000005266. Epub 2023 Jul 5. Obstet Gynecol. 2023. PMID: 37411022
-
Studying Accompaniment model Feasibility and Effectiveness (SAFE) Study: study protocol for a prospective observational cohort study of the effectiveness of self-managed medication abortion.BMJ Open. 2020 Nov 19;10(11):e036800. doi: 10.1136/bmjopen-2020-036800. BMJ Open. 2020. PMID: 33444174 Free PMC article.
-
Comparison of vaginal and buccal misoprostol after mifepristone for medication abortion through 70 days of gestation: A retrospective chart review.Contraception. 2022 Nov;115:62-66. doi: 10.1016/j.contraception.2022.06.012. Epub 2022 Jun 28. Contraception. 2022. PMID: 35772525 Review.
-
Medication abortion.Clin Obstet Gynecol. 2009 Jun;52(2):140-50. doi: 10.1097/GRF.0b013e3181a2b026. Clin Obstet Gynecol. 2009. PMID: 19407520 Review.
Cited by
-
Effectiveness, safety and acceptability of medical abortion at home versus in the clinic: a systematic review and meta-analysis in response to COVID-19.BMJ Glob Health. 2020 Dec;5(12):e003934. doi: 10.1136/bmjgh-2020-003934. BMJ Glob Health. 2020. PMID: 33380413 Free PMC article.
-
Self-managed abortion via the internet: Analysis of one year of service delivery data from Women Help Women.Gates Open Res. 2023 Feb 13;7:41. doi: 10.12688/gatesopenres.14369.1. eCollection 2023. Gates Open Res. 2023. PMID: 37123048 Free PMC article.
-
A qualitative exploration of how the COVID-19 pandemic shaped experiences of self-managed medication abortion with accompaniment group support in Argentina, Indonesia, Nigeria, and Venezuela.Sex Reprod Health Matters. 2022 Dec;30(1):2079808. doi: 10.1080/26410397.2022.2079808. Sex Reprod Health Matters. 2022. PMID: 35713531 Free PMC article.
-
Self-managed abortion as a humanitarian revolution: accounts of a telehealth pilot in the Middle East.Confl Health. 2025 Feb 11;19(1):8. doi: 10.1186/s13031-024-00641-1. Confl Health. 2025. PMID: 39934894 Free PMC article.
-
Aya Contigo: evaluation of a digital intervention to support self-managed medication abortion in Venezuela.Front Glob Womens Health. 2024 Oct 17;5:1401779. doi: 10.3389/fgwh.2024.1401779. eCollection 2024. Front Glob Womens Health. 2024. PMID: 39483289 Free PMC article.
References
-
- Moseson H, Herold S, Filippa S, Barr-Walker J, Baum SE, Gerdts C. Self-managed abortion: a systematic scoping review. Best Pract Res Clin Obstetr Gynaecol. 2020;63:87–110. - PubMed
-
- WHO. Medical management of abortion. Geneva: World Health Organization; 2018. Report No.: ISBN 978-92-4-155040-6
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical